Myelodysplastic Syndrome (MDS) in Humanized Mice
Demographics (2)
- age - Subject age (phv00426534.v1.p1)
- sex - Gender of participant (phv00426535.v1.p1)
Other (17)
- ANALYTE_TYPE - Analyte Type (phv00426541.v1.p1)
- Blast % - Blast percentage in BM (phv00426536.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00426540.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00426526.v1.p1)
- Diagnosis - Diagnosis (phv00426531.v1.p1)
- GENOTYPING_CENTER - Name of the center which conducted genotyping (phv00426544.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00426543.v1.p1)
- IPSS-R - Revised International Prognostic Scoring System (phv00426533.v1.p1)
- IS_TUMOR - Tumor status (phv00426542.v1.p1)
- Karyotype - Karyotype (phv00426537.v1.p1)
- MDS subtype (WHO2016) - MDS subtype (WHO2016) (phv00426532.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00426538.v1.p1)
- SAMPLE_ID - Sample ID (phv00426529.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00426545.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00426530.v1.p1)
- SUBJECT_ID - Subject ID (phv00426525.v1.p1)
- SUBJECT_ID - Subject ID (phv00426528.v1.p1)